Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study
Journal article

Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study

  • Schadendorf, D. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Nestle, F. O. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Broecker, E.-B. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Enk, A. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Grabbe, S. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Ugurel, S. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Edler, L. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
  • Schuler, G. German Cancer Research Center, Mannheim, Germany; University Hospital Zurich, Zurich, Switzerland; University Hospital, Würzburg, Germany; University Hospital, Mainz, Germany; University Hospital, Münster, Germany; German Cancer Research Center, Heidelberg, Germany; University Hospital, Erlangen, Germany
Show more…
Published in:
  • Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2004, vol. 22, no. 14_suppl, p. 7508-7508
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.rero.ch/global/documents/50601
Statistics

Document views: 11 File downloads: